Global DNA Sequencing Products Market 2016-2020

  • ID: 3769367
  • Report
  • Region: Global
  • 64 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AC-Gen Reading Life
  • Beckman Coulter
  • DNA Link
  • Expression Analysis
  • Illumina
  • Oxford Nanopore.
  • MORE
About the DNA Sequencing Products Market

DNA sequencing is categorized into first-generation, second- and next-generation, and emerging technologies. Emerging DNA sequencing technologies are cost-effective and offer more rapid and accurate results than other generation technologies. These technologies find application in the areas of diagnostics, drug and biomarker discovery, personalized medicine, and agriculture and animal research.

Since its introduction in 2010, next-generation DNA sequencing has developed rapidly. It offers insights into various areas of science, particularly healthcare and genomic research. However, available DNA sequencing technologies create significant financial complications for laboratories, increasing the pressure on maintaining the expenses for biomedical research. This has increased the demand for less expensive instruments and the need for cost-effective procedures. It has also increased the emphasis on enhancing aspects of sample preparation and expanding the simplicity of the work process for greater proficiency.

The analysts forecast the global DNA sequencing products market to grow at a CAGR of 18.75% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global DNA sequencing products market for 2016-2020. To calculate the market size, we consider revenue generated from the sale of equipment, reagents, and consumables used in DNA sequencing.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global DNA Sequencing Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- Pacific Biosciences

Other prominent vendors
- AC-Gen Reading Life
- Agilent Technologies
- Beckman Coulter
- Cofactor Genomics
- DNA Link
- Eurofins MWG Operon
- Expression Analysis
- GE HealthCare
- Ototgenetics
- Oxford Nanopore

Market drivers
- Development of rapid sequencing platforms

Market challenges
- Limitations of DNA sequencing technology

Market trends
- Advances in personalized medicine

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AC-Gen Reading Life
  • Beckman Coulter
  • DNA Link
  • Expression Analysis
  • Illumina
  • Oxford Nanopore.
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Benchmark for sequencing companies
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Types of sequencing technology platforms
  • Illumina synthesis
  • Ion semiconductor sequencing
  • Sequencing by ligation
  • Pyrosequencing
  • Single molecule, real-time (SMRT) sequencing
PART 07: Reimbursement and coverage
  • Payer perspective: Validating next-generation sequencing
  • Coding
  • Challenge for payers in US
  • Next-generation tumor sequencing
  • Conclusion
PART 08: Regulation of next-generation sequencing tests in US
  • Analytical performance of next-generation sequencing tests
  • Assessing clinical performance of next-generation sequencing tests
PART 09: Market segmentation by product
  • Global DNA sequencing products market for reagents and consumables
  • Global DNA sequencing products market for equipment
PART 10: Market segmentation by end-user

PART 11: Geographical segmentation
  • DNA sequencing products market in Americas
  • DNA sequencing products market in EMEA
  • DNA sequencing products market in APAC
PART 12: Market drivers
  • Understanding of human genomics
  • Development of rapid sequencing platforms
  • Decline in DNA sequencing costs
  • Incidence of chronic diseases
PART 13: Impact of drivers

PART 14: Market challenges
  • Limitations of DNA sequencing technology
  • Unfavorable reimbursement scenario
  • Limited skilled medical professionals
PART 15: Impact of drivers and challenges

PART 16: Market trends
  • Increase in partnerships and collaborations
  • Advances in personalized medicine
  • Focus on bioinformatics
PART 17: Vendor landscape
  • Competitive scenario
  • Key news
  • Market share analysis 2015
  • Illumina
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Pacific Biosciences
  • Other prominent vendors
PART 18: Appendix
  • List of abbreviations
PART 19: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Cost per genome 2001-2014
Exhibit 03: Cost per megabase of DNA sequence 2001-2014
Exhibit 04: Cost of next-generation sequencing platforms
Exhibit 05: Global DNA sequencing products market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Types of sequencing platforms
Exhibit 08: Global DNA sequencing products market segmentation by product 2015
Exhibit 09: Global DNA sequencing products market for reagents and consumables 2015-2020 ($ billions)
Exhibit 10: Global DNA sequencing products market for equipment 2015-2020 ($ billions)
Exhibit 11: Global DNA sequencing products market segmentation by end-user 2015
Exhibit 12: Global DNA sequencing products market segmentation by geography 2015
Exhibit 13: Global DNA sequencing products market segmentation by geography 2020
Exhibit 14: Global DNA sequencing products market segmentation by geography 2015-2020
Exhibit 15: DNA sequencing products market in Americas 2015-2020 ($ billions)
Exhibit 16: DNA sequencing products market in EMEA 2015-2020 ($ billions)
Exhibit 17: DNA sequencing products market in APAC 2015-2020 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Market share of vendors 2015
Exhibit 21: Illumina: Product portfolio
Exhibit 22: Illumina: Key takeaways
Exhibit 23: Thermo Fisher Scientific: Product portfolio
Exhibit 24: Thermo Fisher Scientific: Key takeaways
Exhibit 25: Roche Diagnostics: Product portfolio
Exhibit 26: Roche Diagnostics: Key takeaways
Exhibit 27: Pacific Biosciences: Key takeaways
Exhibit 28: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AC-Gen Reading Life
  • Beckman Coulter
  • DNA Link
  • Expression Analysis
  • Illumina
  • Oxford Nanopore.
  • MORE
New Report Released: - Global DNA Sequencing Products Market 2016-2020

The author of the report recognizes the following companies as the key players in the global DNA sequencing products market: Illumina, Thermo Fisher Scientific, Roche Diagnostics, and Pacific Biosciences.

Other Prominent Vendors in the market are: AC-Gen Reading Life, Agilent Technologies, Beckman Coulter, Cofactor Genomics, DNA Link, Eurofins MWG Operon, Expression Analysis, GE HealthCare, Otogenetics, and Oxford Nanopore.

Commenting on the report, an analyst from the research team said: “One trend that is expected to boost market growth in a big way is the advances in personalized medicine. Many medical facilities in developed countries and a few in developing countries are implementing DNA sequencing technologies in medical treatment. These facilities use sophisticated technologies and tools such as rapid DNA sequencer for large-scale and quantitative assessments of genomic sequences. These devices have helped make important research discoveries in the area of biomedical sciences. These research results are implemented in clinical settings, particularly in oncology, for the development of personalized medicine.”

According to the report, a key growth driver is the development of rapid sequencing platforms. DNA sequencing has a wide scope in medical diagnosis and personalized treatment options. Sanger and Gilbert methods are first-generation sequencing procedures that were previously used by researchers for genome mapping. Advances in this technology led to the development of second-generation sequencing methods such as pyrosequencing. Further advances led to the development of next-generation sequencing procedures such as Illumina sequencing and 454 sequencing methods. These methods involve the use of advanced technologies, leading to their wide use in various clinical areas.

Further, the report states that one challenge that could hamper market growth is the limitations of DNA sequencing technologies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- Pacific Biosciences
- AC-Gen Reading Life
- Agilent Technologies
- Beckman Coulter
- Cofactor Genomics
- DNA Link
- Eurofins MWG Operon
- Expression Analysis
- GE HealthCare
- Otogenetics
- Oxford Nanopore.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll